M-A | Segurança e eficácia do abacavir no tratamento de bebês, crianças e adolescentes vivendo com HIV.
8 Set, 2022 | 13:45h
Comentário no Twitter
*New meta-analysis* supports the use of #abacavir as a preferred first-line regimen for infants & children living with #HIV
By @jujesson & colleagueshttps://t.co/WSvp5ZOUf1 pic.twitter.com/qFBo5O3zJC
— The Lancet Child & Adolescent Health (@LancetChildAdol) September 5, 2022